Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-05-001496
Filing Date
2005-03-17
Accepted
2005-03-16 21:02:28
Documents
17
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 CRITICAL THERAPEUTICS, INC. b53319cte10vk.htm 10-K 902347
2 EX-10.25 FEASIBILITY STUDY AGREEMENT b53319ctexv10w25.txt EX-10.25 57841
3 EX-10.26 FORM OF INCENTIVE STOCK OPTION AGREEMENT b53319ctexv10w26.txt EX-10.26 7955
4 EX-10.27 FORM OF NONSTATUTORY STOCK OPTION AGREEMENT b53319ctexv10w27.txt EX-10.27 7732
5 EX-10.28 FORM OF RESTRICTED STOCK AGREEMENT b53319ctexv10w28.txt EX-10.28 17097
6 EX-10.29 FORM OF NONSTATUTORY STOCK OPTION AGREEMENT b53319ctexv10w29.txt EX-10.29 7636
7 EX-10.41 AGREEMENT FOR MANUFACTURING AND SUPPLY b53319ctexv10w41.txt EX-10.41 266700
8 EX-10.42 2005 COMPANY GOALS b53319ctexv10w42.txt EX-10.42 767
9 EX-21.1 SUBSIDIARIES OF THE REGISTRANT b53319ctexv21w1.txt EX-21.1 814
10 EX-23.1 CONSENT OF DELOITTE & TOUCHE LLP b53319ctexv23w1.txt EX-23.1 602
11 EX-31.1 SECTION 302 CERTIFICATION OF CEO b53319ctexv31w1.txt EX-31.1 3540
12 EX-31.2 SECTION 302 CERTIFICATION OF CFO b53319ctexv31w2.txt EX-31.2 3594
13 EX-32.1 SECTION 906 CERTIFICATION OF CEO b53319ctexv32w1.txt EX-32.1 1331
14 EX-32.2 SECTION 906 CERTIFICATION OF CFO b53319ctexv32w2.txt EX-32.2 1424
16 GRAPHIC b53319ctb5331900.gif GRAPHIC 12603
17 GRAPHIC b53319ctb5331901.gif GRAPHIC 11441
18 GRAPHIC b53319ctb5331902.gif GRAPHIC 13013
  Complete submission text file 0000950135-05-001496.txt   1320272
Mailing Address 60 WESTVIEW STREET LEXINGTON MA 02421
Business Address 60 WESTVIEW STREET LEXINGTON MA 02421 781-402-5700
CRITICAL THERAPEUTICS INC (Filer) CIK: 0001145404 (see all company filings)

EIN.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50767 | Film No.: 05687205
SIC: 2834 Pharmaceutical Preparations